4-Butyl-4'-((4-butyl-2,6-difluorophenyl)ethynyl)-1,1'-biphenyl, 98%, 1g

(S)-tert-Butyl 1-(2-fluorobenzyl)pyrrolidin-3-ylcarbamate, 95.0%, 1g

Ethyl 2-methoxy-6-methylbenzoate, 95.0%, 25g

2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-(pent-4-en-1-yl)hept-6-enoic acid, 97%, 100mg

(S)-1-(4-BROMO-2-FLUOROPHENYL)ETHANAMINE HCL, 97.0%, 1g

Recipiente de cristalización DURAN® sin pico, 150 ml, 80 mm, 10 Unidad(es)

3-(4-Bromo-2-fluorophenyl)-2-methyl-1-propene, 97.0%, 2g

4,4',4'',4'''-(Ethene-1,1,2,2-tetrayl)tetraaniline, 97.0%, 1g

6,7-dibromo-1H,4H-pyrrolo[2,1-f][1,2,4]triazin-4-one, 97%, 10g

(S)-1-(4-Bromothiophen-2-yl)ethan-1-amine, 95%, 250mg

2-(tert-Butyl)-6-chloro-N-methoxy-N-methylbenzo[d]oxazole-7-sulfonamide, 95.0%, 1g

5-(Methoxycarbonyl)piperidine-3-carboxylic acid, 98%, 5g

Isobutene (ca. 10% in Isopropyl Ether)100mL